Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Exchange Rate Effect (2022 - 2025)

Strata Critical Medical (SRTA) reported Exchange Rate Effect of -$616000.0 for Q3 2025, down 1093.55% year-over-year from $62000.0 in Q3 2024, and down 507.95% on a QoQ basis from $151000.0 in Q2 2025.

Strata Critical Medical (SRTA) has 4 years of Exchange Rate Effect data on file, last reported at -$616000.0 in Q3 2025.

  • Quarterly Exchange Rate Effect fell 1093.55% year-over-year to -$616000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$465000.0 (down 745.83% YoY) and the FY2025 annual result came in at -$339000.0, down 323.75% from the prior year.
  • Exchange Rate Effect declined to -$616000.0 in Q3 2025 per SRTA's latest filing, from $151000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $151000.0 in Q2 2025 and bottomed at -$616000.0 in Q3 2025.
  • The 4-year median for Exchange Rate Effect is $3000.0 (2022), against an average of -$36538.5.
  • Peak annual rise in Exchange Rate Effect reached 2257.14% in 2025, while the deepest fall reached 1093.55% in 2025.
  • Tracing SRTA's Exchange Rate Effect over 4 years: stood at $7000.0 in 2022, then surged by 114.29% to $15000.0 in 2023, then tumbled by 826.67% to -$109000.0 in 2024, then tumbled by 465.14% to -$616000.0 in 2025.
  • Per Business Quant, the three latest SRTA Exchange Rate Effect figures stand at -$616000.0 (Q3 2025), $151000.0 (Q2 2025), and $126000.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -2.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 259,000.00
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -924,000.00
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -37.45 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Strata Critical Medical 538.39 Mn 479.60 Mn 14.12 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -616,000.00
Sep 30, 2025 -616,000.00
Jun 30, 2025 151,000.00
Jun 30, 2025 151,000.00
Mar 31, 2025 126,000.00
Mar 31, 2025 126,000.00
Dec 31, 2024 -109,000.00
Dec 31, 2024 -109,000.00
Sep 30, 2024 62,000.00
Sep 30, 2024 62,000.00
Jun 30, 2024 -7,000.00
Jun 30, 2024 -7,000.00
Mar 31, 2024 -26,000.00
Mar 31, 2024 -26,000.00
Dec 31, 2023 15,000.00
Dec 31, 2023 15,000.00
Sep 30, 2023 -101,000.00
Sep 30, 2023 -101,000.00
Jun 30, 2023 17,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 3,000.00
Mar 31, 2023 3,000.00
Jun 30, 2022 7,000.00
Jun 30, 2022 7,000.00
Mar 31, 2022 3,000.00
Mar 31, 2022 3,000.00